Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ADRIAMYCIN RDF INJ 150MG/VIAL 150 MG

DOXORUBICIN HYDROCHLORIDE : 150 MG · DIN 00768766 · ADRIA LABORATORIES OF CANADA LTD.

Health Canada status: CANCELLED POST MARKET

What is ADRIAMYCIN RDF INJ 150MG/VIAL?

ADRIAMYCIN RDF INJ 150MG/VIAL 150 MG contains DOXORUBICIN HYDROCHLORIDE : 150 MG. It is listed in the Health Canada Drug Product Database under DIN 00768766, held by ADRIA LABORATORIES OF CANADA LTD., supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 10-Sep-1996. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN00768766
Brand nameADRIAMYCIN RDF INJ 150MG/VIAL
Generic / active ingredientDOXORUBICIN HYDROCHLORIDE : 150 MG
ManufacturerADRIA LABORATORIES OF CANADA LTD.
Strength150 MG
Dosage formPOWDER FOR SOLUTION
Route of administrationINTRAVENOUS
SchedulePrescription
ATC codeL01DB01 DOXORUBICIN
AHFS class10:00.00
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date10-Sep-1996
Original market date1988-12-31 00:00:00

Is DOXORUBICIN in shortage in Canada?

A Canadian shortage report is on file for this molecule: Active — reported by TEVA CANADA LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for ADRIAMYCIN RDF INJ 150MG/VIAL

What can be used instead?

Other Canadian products sharing ATC code L01DB01 DOXORUBICIN. 7 of 25 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
CAELYX2 MGSUSPENSIONBAXTER CORPORATIONMARKETEDDIN 02238389
DOXORUBICIN2 MGSOLUTIONPFIZER CANADA ULCMARKETEDDIN 02410397
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP150 MGPOWDER FOR SOLUTIONPFIZER CANADA ULCMARKETEDDIN 02194473
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP50 MGPOWDER FOR SOLUTIONPFIZER CANADA ULCMARKETEDDIN 02194465
DOXORUBICIN HYDROCHLORIDE INJECTION2 MGSOLUTIONTEVA CANADA LIMITEDMARKETEDDIN 02409275
DOXORUBICIN INJECTION, BP2 MGSOLUTIONACCORD HEALTHCARE INCMARKETEDDIN 02381982
TARO-DOXORUBICIN LIPOSOMAL2 MGSUSPENSIONTARO PHARMACEUTICALS INCMARKETEDDIN 02493020
ADRIAMYCIN PFS2 MGSOLUTIONPFIZER CANADA ULCDORMANTDIN 02071002
ADRIAMYCIN RDF10 MGPOWDER FOR SOLUTIONPFIZER CANADA ULCCANCELLED POST MARKETDIN 02065657
ADRIAMYCIN RDF150 MGPOWDER FOR SOLUTIONPFIZER CANADA ULCCANCELLED POST MARKETDIN 02069563

Who else supplies DOXORUBICIN worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. DOXORUBICIN appears in 108 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for ADRIAMYCIN RDF INJ 150MG/VIAL

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for ADRIAMYCIN RDF INJ 150MG/VIAL

Health Canada Drug Product Database (DPD), DIN 00768766. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.